Kohei Taniguchi

Osaka University of Pharmaceutical Sciences

Papers

4

Total Citations

18

H-Index

3

About

Kohei Taniguchi is a surgeon-researcher advancing the frontiers of gynecologic oncology through minimally invasive and robotic surgical techniques. His work centers on improving outcomes for patients with cervical, endometrial, and rectal cancers, with a particular focus on comparing surgical approaches and refining sentinel lymph node procedures. Taniguchi’s most impactful study, with 8 citations, critically evaluated prognosis in early-stage cervical cancer, revealing that minimally invasive radical hysterectomy may carry higher recurrence risks than the abdominal approach—a finding that challenges prevailing clinical assumptions. He further demonstrated leadership in surgical innovation by developing a robot-assisted modified radical hysterectomy that uses indocyanine green to map and remove lymphatic vessels, enhancing safety in endometrial cancer treatment. His 2024 real-world analysis of over 1,000 rectal cancer cases from a Japanese nationwide database showed that robotic surgery offers comparable short-term outcomes to laparoscopy but at higher perioperative costs, providing essential data for resource allocation. Taniguchi’s work, spanning 2022 to 2024, has accumulated over 18 citations, establishing him as a careful evaluator of oncologic outcomes and a proponent of evidence-based surgical evolution.

Research Focus

Key Achievements

3
H-Index
4
Papers
18
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of Prognosis between Minimally Invasive and Abdominal Radical Hysterectomy for Patients with Early-Stage Cervical Cancer
8 citations · 2022
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 25
🏛 Institutions: Osaka University of Pharmaceutical Sciences

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago